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Thebrainchangesinresponsetoexperienceandalteredenvironment.Todothat,thenervoussystemoftenremodelsthestructures
ofneuronalcircuits.Thisstructuralplasticityoftheneuronalcircuitsappearstobecontrollednotonlybyintrinsicfactors,butalso
by extrinsic mechanisms including modiﬁcation of the extracellular matrix. Recent studies employing a range of animal models
implicate that matrix metalloproteinases regulate multiple aspects of the neuronal development and remodeling in the brain. This
paper aims to summarize recent advances of our knowledge on the neuronal functions of matrix metalloproteinases and discuss
how they might relate in neuronal disease.
1.Introduction
In higher vertebrates, the space between neural cells in
the brain is ﬁlled with material of the extracellular matrix
(ECM). Both neurons and glial cells contribute to the
production of the ECM components, and the ECM in
turn mediates various structural and functional interactions
between these cells [1, 2]. During early development, the
ECM plays crucial roles in proliferation, migration and
diﬀerentiation of neural cells. In the mature brain, the ECM
undergoes a slow turnover and supports multiple physio-
logical processes. In general, the mature ECM environment
seems inhibitory for structural plasticity of neuronal circuits.
For example, chondroitin sulfate proteoglycans appear to
be one of inhibitory components in the ECM because
their degradation by chondroitinase can reactivate ocular
dominance plasticity [3]. It is thus likely that regulated
proteolytic alteration of the ECM microenvironment should
be required for the structural plasticity of neuronal circuits.
The ECM modiﬁcations in the nervous system are
likely achieved by the concerted actions of several diﬀerent
proteases that are secreted by neurons and glial cells [4–
6]. Among these proteinases, the matrix metalloproteinases
(MMPs) family stands out as likely regulators of the neural
plasticity. The mammalian central nervous system (CNS)
contains over 10 diﬀerent MMPs with detectable levels
of transcripts or proteins [7, 8]. Studies of the temporal
and spatial expression patterns of MMPs in the developing
nervous system suggest that MMPs play important roles
in neuronal development. In addition, expression of many
MMPs has shown to change in response to injury or
neurological disease [9]. Knockouts of particular MMPs
signiﬁcantly aﬀect the injury and pathology, indicating
that MMPs function as the crucial mediators of neuronal
disease [10–12]. Interestingly, several MMP knockouts show
deﬁcits in learning and memory [10, 11]. Consistent with
these notions, MMPs likely mediate the structural changes
of dendritic spines as well as axon/dendrite structures in
response to neuronal activity and in mental diseases [10, 11].
This paper considers potential roles for MMPs in neuronal
development and plasticity, and discusses its alteration in
injury and disease states.
2 .M M P sint h eN e rv o usS ys t e m
Currently, 24 mammalian MMPs have been identiﬁed with
distinct yet overlapping substrate speciﬁcities (Figure 1).2 Biochemistry Research International
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Figure 1: Domain structures of typical MMP family members in mammal and fruit ﬂy. Hinge, hinge region; PM, plasma membrane; TM,
transmembrane domain; GPI, glycosyl-phosphatidylinositol linker. The signal sequence located at the amino terminus of all prodomain is
not shown.
Several MMPs are membrane anchored by transmembrane
domains (MMP-14, -15, -16, -24) or by GPI links (MMP-
17, -25). The expression of many MMPs has been detected
in the nervous system and shown to change in response to
injury and neurological disease [6–8]. Analysis of mRNA
expression in the brain and spinal cord showed that MMP-
2, -9, -11, -12, -13, -14, -15, and -24 are developmentally
regulated, whereas mRNA levels of MMP-3, -7, and -10
remain unchanged throughout the neural development [6–
8].Sofar,twosecretedtypesofMMPs,MMP-2,andMMP-9,
are most frequently investigated MMPs in the brain because
they are relatively easily detectable. MMP-2 is detected
in various brain structures including astroglia and some
pyramidal neurons in the cortex and Purkinje cells in the
cerebellum, whereas MMP-9 is expressed in the hippocam-
pus, cerebellum, and cortex, predominantly in neurons [6–
8]. Levels of MMP-2 and MMP-9 are signiﬁcantly elevated
following ischemia, brain injury, and kainate treatment [6,
11], implying a role for MMP-2 and MMP-9 in remodeling
of neural circuits in response to neural activity and brain
damages.
In the fruit ﬂy Drosophila melanogaster, there are only
two MMP family members: Mmp1 and Mmp2 [13]. Mmp1
is a secreted proteinase, whereas Mmp2 is a GPI-anchored
protein(Figure 1).ExpressionlevelsofMmp1andMmp2are
dramatically elevated during metamorphosis in many tissues
including the nervous system [13]. In agreement with the
expression pattern, recent reports indicate that Mmp1 and
Mmp2 play critical roles in remodeling of neural circuits in
the peripheral nervous system [14, 15].
3.SecretedMMPsinStructuraland
FunctionalPlasticityof Synapses
Dendritic spine morphology and synaptic potentiation can
both be dynamically modulated by proteins of the ECM
and the cell-surface proteins with which they interact, which
has long fueled the idea that regulated ECM remodeling
has an important role in synaptic plasticity [16]. In the
brain, MMPs are secreted by neurons and glial cells in an
inactive (pro)form, and they become proteolytically active
when several regulatory steps that result in removal of the
propeptide are triggered in response to speciﬁc stimuli [5].
For example, studies have shown that in response to long-
term potentiation (LTP) induction, MMP-9 rapidly becomes
proteolytically active at perisynaptic sites and is essential for
maintenance of LTP [17, 18]. Thus, perisynaptic MMP-9
proteolysis in response to LTP induction is likely critical for
local remodeling of dendritic spine structures and functions
necessary to support long-term synaptic plasticity [19–21].
LTP is a widely used cellular model for long-lasting
synaptic plasticity that is thought to underlie learning
and memory. MMP-9 knockout mice show behavioral
impairments in hippocampus-dependent associative learn-
ing [11]. Furthermore, hippocampal slice cultures from
MMP-9 knockout mice show impaired LTP, which can be
restored by the application of recombinant MMP-9 [11].
In other studies, transient induction of hippocampal MMP-
9 and MMP-3 levels was observed when animals were run
in the Morris water maze, further supporting a role for
MMPs in hippocampus-dependent learning [18]. Although
the precise molecular mechanisms involved remain unclear,Biochemistry Research International 3
MMP-mediated synaptic potentiation can be inhibited in
hippocampal slices by blocking integrin signaling, which
suggests that MMP-9 regulates synaptic plasticity and LTP
through integrins [11]. MMP-9 may exert its eﬀects on
integrins through the cleavage of laminin or other ECM
components, exposing otherwise inaccessible RGD sites that
can induce integrin signaling. It is also possible that MMP-9
may yield signaling functions through CD44 and integrins as
shown in B cell lymphomas [22].
Alternatively, MMP-9 could regulate LTP by promot-
ing lateral movement of glutamate receptors in excitatory
synapses. Many synapses in the mature CNS are wrapped
by a dense ECM, which likely acts as a spatial obsta-
cle for glutamate receptors including N-methyl-D-aspartic
acid- (NMDA-) type and alpha-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic-acid- (AMPA) type receptors. It is thus
assumed that modiﬁcation of the ECM components might
facilitate structural and functional plasticity in synapses.
Indeed, a recent study using a high-resolution ﬂuorescent
in situ zymography (ISZ) shows colocalization of MMP-9
with synaptic glutamate receptors [23]. Michaluk et al. [24]
showed that addition of recombinant MMP-9 in hippocam-
pal cultured neurons increased lateral diﬀusion of NMDA
receptors but not AMPA receptors. They further showed
that the motility change was not mediated by alteration in
the net ECM structure nor by direct cleavage of NMDA
receptors, but rather through modiﬁcation of an integrin-
dependent pathway [24]. On the other hand, Frischknecht
et al. [25] indicated that enzymatic removal of the ECM
increased extrasynaptic receptor diﬀusion and the exchange
of synaptic AMPA receptors but not NMDA receptors. It is
thus possible that membrane diﬀusion of AMPA and NMDA
receptors is diﬀerently regulated by the ECM and MMPs in
synapses, which may contribute to functional diﬀerence of
AMPA and NMDA receptors in synaptic plasticity.
4.M M P sinA x o nR eg e ne ratio n
Several lines of evidence point toward a potential role of
MMPs in axonal regeneration following an injury. First,
expression of MMPs has been shown to correspond with
periods of recovery [26]. In regenerating sciatic nerve
ﬁbers,MMP-9expressioniscolocalizedwithphosphorylated
neuroﬁlament M, a marker for regenerative elongation [27].
Furthermore, the phosphorylated neuroﬁlament M is also
induced by MMP-9 treatment and inhibited by an anti-
MMP-9 antibody treatment [27]. Regenerating axons also
show immunoreactivity for MMP-2 and MMP-3 [28].
A second line of evidence comes from studies of their
application to nonpermissive substrates. When primary
dorsal root ganglion (DRG) neurons are grown on cryostat
sections of normal adult nerves, neurite outgrowth is poor
as the adult nerves constitute an unfavorable substrate.
However, when the nerve sections are treated with MMP-2,
which degrades inhibitory chondroitin sulfate proteoglycans
(CSPGs) to expose permissive laminin, neurite outgrowth
from DRG neurons is promoted [29]. In a chronically den-
ervated distal tibial nerve segments, successful regeneration
of axons is facilitated by supernatant from a neural stem cell
line containing large quantities of secreted MMP-2, which
likely degrades the CSPGs in the chronically denerved nerve
sections [30].
Wallerian degeneration occurs after injury and involves
the breakdown of myelin and axons, and removal of
degenerating nerve components. This clearance is necessary
for eventual repair. MMP levels increase during Wallerian
degeneration, and this correlation is functionally signiﬁcant
as Wallerian degeneration of a transected nerve is delayed by
MMP inhibitors [31].
In summary, the data for MMPs in axonal regeneration is
scantbutstillsuggestive.Moredeﬁnitiveevidence,perhapsin
the form of application of MMPs to an area of injury in vivo
to improve axonal regrowth, is required.
5. Membrane-Anchored MMPs Promote
DendriteRemodeling
The ECM exerts a strong inﬂuence on dendrite morpho-
genesis in cultured neurons, as the ECM can aﬀect dendrite
patterning in part through ECM-neurite adhesive contacts
mediated by cell adhesion molecules such as integrins
[32]. ECM-neurite interactions have also been implicated
in regulating structural plasticity of dendrites in vivo.F o r
instance, blockage of the integrin-ECM interaction in RGCs
[33] or genetic ablation of the integrin-mediated signaling in
adult cortical neurons [34] causes progressive retraction of
dendritic branches.
The ECM modiﬁcations in the nervous system are
likely achieved by the concerted actions of several diﬀerent
proteases that are secreted by neurons and glial cells [4–
6]. Among these many proteases, MMPs stand out as likely
regulators of the dendrite development and pathology since
MMPs are dramatically upregulated in particular neurons of
thedeveloping brainandareoftencolocalizedwithdendrites
[35, 36]. However, in large part due to issues of redundancy
and compensation among over 20 vertebrate MMP family
members, the in vivo role of MMPs in the nervous system
remains to be established (Table 1).
Ar e c e n ts t u d yo nDrosophila P N Sn e u r o n sh a sp r o v i d e d
in vivo evidence that ECM degradation facilitates dendrite
remodeling [15]. During metamorphosis, the larval den-
dritic arbors of class IV sensory neurons are completely
replaced with adult-speciﬁc processes as a result of extensive
pruning and subsequent regeneration of dendritic arbors
[14, 46]. Similar to their larval counterparts, dendrites of
adult class IV neurons initially elaborate dendritic trees in
a radial fashion and covered the whole body wall prior to
eclosion. However, in contrast to what is observed during
larval development [47–49], this radial arrangement of
the dendritic arbor is rapidly rearranged to a lattice-like
shape within 24h after eclosion [15]. Time-lapse imaging
revealed that this radial-to-lattice reshaping is largely due to
rearrangement of the existing radial processes into a lattice-
like pattern, rather than extensive pruning of the radially-
arranged dendrites followed by regrowth of new arbors
into a lattice pattern (Figure 2). Mutations in Mmp2, which4 Biochemistry Research International
Table 1: MMP family proteins in neural circuit remodeling.
Mammalian Fruit ﬂy
Synapse remodeling MMP-3, -7, -9, -24
[11, 16–25] No reports available
Axon regeneration MMP-2, -3, -9,
[27–31, 37] Mmp1/2 [38, 39]
Dendrite remodeling MMP-2, -9, -24
[40, 41] Mmp1/2 [14, 15]
Neurogenesis MMP-2, -9 [42–45]N o r e p o r t s a v a i l a b l e
72 hr 0 hr
(a)
Epidermis
Basement
membranes
Radial dendrites Lattice-like dendrites
Mmp2
(b)
Figure 2: Dendrite reshaping in Drosophila sensory neurons is mediated by matrix metalloproteinases. (a) Dendritic pattern of a single class
IV neurons in 0hr and 72hr posteclosion adults. (b) Dendrites of Drosophila sensory neurons are rapidly reshaped within 24 hours after
eclosion. This dendrite reshaping is promoted by the matrix metalloproteinase Mmp2-mediated degradation of the basement membrane,
suggesting that proteolytic alteration of the extracellular matrix plays a fundamental role in remodeling of dendritic structures during
reorganization of neuronal circuits. This model is predominantly based on data from [15].
encodes a GPI-anchored matrix metalloproteinase, block
this radial-to-lattice reshaping of class IV dendrites without
aﬀecting other aspects of dendrite growth or development,
and Mmp2 expression in epithelial cells adjacent to class IV
dendrites is transiently increased at exactly the time when
class IV dendrites undergo the radial-to-lattice reshaping.
Therefore,epithelial Mmp2 promotes the dendrite reshaping
throughlocalmodiﬁcationofthebasementmembrane(BM)
upon which class IV dendrites grow. These observations
indicatethatalterationoftheECMmicroenvironmentmight
be a general mechanism for driving the structural plasticity
of dendritic arbors in vivo (Figure 2).
In the mouse cerebellum, membrane-type 5 MMP
(MT5-MMP; also named as MMP-24) is expressed in
developing dendrites of Purkinje cells, implicating a role for
MT5-MMPin dendrogenesis [35].ThepreciserolesofMT5-
MMP in the cerebellum are not known. Since structural
remodeling in dendrites as well as synapses is reported in
developing Purkinje cells [50], it is of interest to examine
if membrane-anchored MMPs including MT5-MMP mayBiochemistry Research International 5
play a role in dendrite remodeling the mammalian nervous
system.
6. PotentialRoles of MMPs in Neurogenesis
MMPs have recently been considered to be involved in the
neurogenic response of adult neural stem/progenitor cells.
MMPs are expressed abundantly in neural stem cells isolated
from the human CNS [42]. Brain injuries including ischemia
enhance neurogenesis in neuroproliferative regions of the
adult rodent brain such as the subventricular zone (SVZ)
of the lateral ventricles and the subgranular zone (SGZ) of
the dentate gyrus (DG) of the hippocampus [43]. Although
mostMMPsareexpressedatverylowlevelsintheadultCNS,
mRNA expression of both MMP-9 and MMP-2 increased
severalfold in neural progenitor cells of SVZ after ischemic
insult in adult rats [44]. Similarly, upregulation of MMP-9
and MMP-2 in the SGZ of the dentate gyrus was compatible
with the peak of postischemic neurogenesis in adult primate
brains [45]. These observations suggest that MMPs could
be an important component in neurogenesis-associated
processes in postischemic brain hippocampus. Physiological
signiﬁcance of the MMP expressions in the neurogenic
regions remains to be determined. One likely possibility
is that, as shown in the developing brain, MMPs might
promote proliferation, neurite extension, and migration of
newly born neurons. Alternatively, MMPs might play a role
in providing an optimal niche for neural stem/progenitor
cells by modulating the ECM environment.
7. MMPs inNeuronalInjuryandDisease
MMP expression levels are elevated after nervous system
injury and in a number of neuronal pathologies. For exam-
ple, MMP-9 expression is elevated shortly after ischemia
and stroke [9]. Likewise, multiple MMPs including MMP-
3, -7, -10, -11, -19, and -20 are immediately induced within
24h of an acute insult such as spinal cord compression
injury [51]. During the period of peak signs in experimental
autoimmune encephalomyelitis (EAE), an animal model of
multiple sclerosis and the transcripts encoding the majority
of MMPs are elevated [52]. In epileptogenesis, serum MMP-
9 levels and the ratio of MMP-9 to tissue inhibitor of
metalloproteinase-1 are elevated in children with various
febrile seizures and convulsive status epilepticus [53]. After
seizure, MMP-9 mRNA is transported to dendrites and
synapses in the hippocampal DG of kainic acid-treated rats
[54]. Wilczynski et al. showed that the sensitivity to PTZ
epileptogenesis was decreased in MMP-9 knockout mice but
is increased in transgenic rats overexpressing MMP-9 [41].
The increase of many MMPs in CNS pathology raises
the question of which of these enzymes are important for
the pathophysiological process. The alleviation of disease
pathology in response to MMP inhibitors shows that the
net eﬀect of the expression of MMPs in CNS injury is
detrimental. In this regard, MMP-9 null mice have been
f o u n dt ob el e s sa ﬄicted than wild-type mice by EAE and
stroke, whereas MMP-9 and MMP-12 null mice recover
better from spinal cord injury [55, 56]. MMP-2 null mice
have been found to be more suspective to EAE, which have
been attributed to compensatory increase in MMP-9 in these
animals [57]. In the mouse model of EAE, MMP-9 promotes
development and progression of the disease whereas MMP-
12 has a role in its resolution [58], suggesting that diﬀerent
MMPs might have distinct roles in EAE development.
Indeed, double MMP-2 and -9 knockout mice are resistant
to EAE development [59], indicating that combined MMP-2
and -9 activities are crucial EAE.
In addition to the brain injury and diseases, MMPs are
implicated in drug addiction. The MMP inhibitors often
suppressed acquisition of cocain-induced conditioned place
preference (CPP) [60]. In consistent with the inhibitor
studies, MMP protein levels in the brain were changed in
cocain abusers as well as cocain-treated animals [61]. The
roleofMMPsindrugaddictionwasfurtherconﬁrmedbythe
ﬁndings that MMP-2 and MMP-9 deﬁcient mice displayed
attenuated sensitization and cocain CPP [62, 63].
MMPs are recently shown to be involved in development
of neuropathic pain, which is characterized by mechanical
allodynia that is, painful responses to previously nonpainful
mechanical stimuli [64]. In L5 spinal nerve ligation, MMP-9
shows a rapid and transient upregulation in the injured DRG
sensory neurons, whereas MMP-2 shows a delayed response
in DRG satellite cells and spinal astrocytes. Local inhibition
of MMP-9 by an intrathecal route inhibits the early phase of
neuropathic pain, whereas inhibition of MMP-2 suppresses
the late phase of neuropathic pain. These results suggest that
distinct MMPs play diﬀerent roles in early and late-phase
development of neuropathic pain and that MMP inhibitors
may provide a therapeutic approach for the treatment of
neuropathic pain.
A recent report suggests a possible role of MMPs in
Huntington’s disease (HD) pathogenesis [65]. HD, the most
frequent of a group of nine inherited neurodegenerative
polyglutamine disorders, is caused by an expanded CAG
triplet repeat in exon 1 of the huntingtin gene that encodes
a stretch of polyglutamine (polyQ) residues close to the
N-terminus of the huntingtin (Htt) protein. Htt is known
to be cleaved by various proteases including Caspases and
calpains, and inhibition of the mutant Htt proteolysis
reduces neurotoxicity, indicating an important role for Htt
proteolysis in HD pathogenesis. Miller et al. examined Htt
proteolytic processing by screening for enzymes that cleave
mutant Htt and found that MMP-10 is responsible for the
Htt proteolysis to produce small N-terminal toxic fragments.
A nonpeptidic inhibitor of MMPs NNHG, and two known
endogenous MMPs inhibitors, TIMP1 and TIMP3, blocked
Htt-mediated toxicity and produced beneﬁcial therapeutic
eﬀects, providing new insights into Htt proteolysis and its
potential as a therapeutic target.
8.FuturePerspectives
This paper highlights the diversity and importance of MMPs
in neuronal development, plasticity, and maintenance of
neuronal health. Many questions await further studies,6 Biochemistry Research International
including which member or members of the MMPs are
important in a particular condition or pathological state,
how they achieve their eﬀects, and what roles each MMP has
in the overall scheme. MMPs are also implicated in diseases
of the nervous system, and it is important to target their
activity for therapy. The study of MMP functions should
open up new vistas in the nervous system physiology and
pathology.
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